Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2012 Q2- Text added to 2012 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Abbott, Academy, accelerate, adding, aimed, alfa, Allergy, animal, anniversary, appointing, appointment, argument, aseptic, attenuated, await, Bachelor, beractant, Cambrex, carefully, casualty, cellular, Center, CERF, chemical, Chiesi, Colorado, contemplated, Counter, CounterACT, deny, deployed, destruction, diagnostic, dysfunction, Excellence, extend, Farmaceutici, fewer, firm, flood, homogenously, immaterial, inflammatory, insert, Interagency, intervention, Italy, length, Leone, local, long, lose, Military, motivate, movement, NIAID, NIH, Nuclear, outright, Parma, past, pathophysiological, Paul, penetration, PICU, poractant, proactively, progression, promptly, radiation, remediation, return, robust, Rochester, root, routine, satisfaction, Science, shipment, situated, SRT, strictly, submission, suggestive, threat, timeframe, translational, uniform, unpredictable, upgrade, uptake, verify, ViroPharma, warehouse, West, widely
Valuein 2012 Q2 filing- Value in 2012 Q3 filing
Original filings
Filing view